ConductScience.org, home

Paper39308

Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.

Caraceni T and 6 others. Psychopharmacology (Berl), 1979. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy. Papers, record 39308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39308

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.
PubMed
Journal
Psychopharmacology (Berl)
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.36
iCite
Revised in PubMed
2019-07-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Caraceni TT
2Parati EAE A
3Girotti FF
4Celano II
5Frigerio CC
6Cocchi DD
7Müller EEE E

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BehaviorMajor topic
LevodopaMajor topic
MSH Release-Inhibiting HormoneMajor topic
Parkinson DiseaseMajor topic
Aged
Female
Growth Hormone
Humans
Male
Middle Aged
Placebos
Prolactin
Time Factors

Source PubMed

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,332A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.Eur J Pharmacol1976https://conductscience.org/library/papers/4332PubMed
2988,503Central site of action of somatostatin (SRIF): role of hippocampus.Neuropharmacology1976https://conductscience.org/library/papers/988503PubMed
34,633,626Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide.Neuroendocrinology1973https://conductscience.org/library/papers/4633626PubMed
44,156,639Pharmacological studies with a tripeptide, prolyl-leucyl glycine amide.Arch Int Pharmacodyn Ther1974https://conductscience.org/library/papers/4156639PubMed
55,283,931Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone.Proc Natl Acad Sci U S A1971https://conductscience.org/library/papers/5283931PubMed
6591,982Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.J Neurol Neurosurg Psychiatry1977https://conductscience.org/library/papers/591982PubMed
74,569,230Clinical experience with hypothalamic releasing hormones. 2. Luteinizing hormone-releasing hormone and other hypophysiotropic releasing hormones.Recent Prog Horm Res1972https://conductscience.org/library/papers/4569230PubMed
84,569,233Studies on prolactin in man.Recent Prog Horm Res1972https://conductscience.org/library/papers/4569233PubMed
94,947,365DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).Life Sci I1971https://conductscience.org/library/papers/4947365PubMed
104,209,275Hypothalamic releasing factors and Parkinson disease.Arch Neurol1974https://conductscience.org/library/papers/4209275PubMed
1113,412Effects of L-prolyl-L-leucyl-glycine amide (MIF-I) on dopaminergic neurons.Pharmacol Biochem Behav1976https://conductscience.org/library/papers/13412PubMed
124,640,811Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.Can Med Assoc J1972https://conductscience.org/library/papers/4640811PubMed
1313,417MIF, TRH, and simian social and motor behavior.Pharmacol Biochem Behav1976https://conductscience.org/library/papers/13417PubMed
145,064,701Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF).Proc Soc Exp Biol Med1972https://conductscience.org/library/papers/5064701PubMed
154,614,981Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom.Eur Neurol1974https://conductscience.org/library/papers/4614981PubMed
164,116,150Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone.Lancet1972https://conductscience.org/library/papers/4116150PubMed
174,858,836DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide.Neuroendocrinology1974https://conductscience.org/library/papers/4858836PubMed
1814,213,659A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA.Nature1964https://conductscience.org/library/papers/14213659PubMed
195,969,830Hypersensitivity induced in albino mice by melanocyte-stimulating hormone.Nature1966https://conductscience.org/library/papers/5969830PubMed
205,655,944Critical analysis of the disability in Parkinson's disease.Mod Treat1968https://conductscience.org/library/papers/5655944PubMed

See all 23 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn Papers
33,202,534Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33202534

Source PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GH12,688PubTator's text mininghttps://conductscience.org/library/genes/2688NCBI Gene
PRL5,617PubTator's text mininghttps://conductscience.org/library/genes/5617NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39308

GET https://conductscience.org/api/papers/v1/39308/references?page=2